澳大利亚国家药品政策

L Sansom PhD, FPS
{"title":"澳大利亚国家药品政策","authors":"L Sansom PhD, FPS","doi":"10.1046/j.1440-1762.1999.00291.x","DOIUrl":null,"url":null,"abstract":"<p> <b>Abstract</b> A responsibility of Government is to ensure that safe and efficacious medicines are available for people, from local industry, to treat illness and to maintain health. However, the cost of these medications to the public must be such that access is not denied because of financial barriers. Accessibility alone does not ensure that health outcomes are maximized. It is also necessary to have in place structures and processes which involve all stakeholders in ensuring the quality use of medicines. All of these components need to be incorporated in a national, co-ordinated policy which acts as a reference point for appropriate drug use, policy development and evaluation.</p>","PeriodicalId":79407,"journal":{"name":"Journal of quality in clinical practice","volume":"19 1","pages":"31-35"},"PeriodicalIF":0.0000,"publicationDate":"2002-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1046/j.1440-1762.1999.00291.x","citationCount":"17","resultStr":"{\"title\":\"The Australian National Medicinal Drug Policy\",\"authors\":\"L Sansom PhD, FPS\",\"doi\":\"10.1046/j.1440-1762.1999.00291.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p> <b>Abstract</b> A responsibility of Government is to ensure that safe and efficacious medicines are available for people, from local industry, to treat illness and to maintain health. However, the cost of these medications to the public must be such that access is not denied because of financial barriers. Accessibility alone does not ensure that health outcomes are maximized. It is also necessary to have in place structures and processes which involve all stakeholders in ensuring the quality use of medicines. All of these components need to be incorporated in a national, co-ordinated policy which acts as a reference point for appropriate drug use, policy development and evaluation.</p>\",\"PeriodicalId\":79407,\"journal\":{\"name\":\"Journal of quality in clinical practice\",\"volume\":\"19 1\",\"pages\":\"31-35\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1046/j.1440-1762.1999.00291.x\",\"citationCount\":\"17\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of quality in clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1046/j.1440-1762.1999.00291.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of quality in clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1046/j.1440-1762.1999.00291.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

摘要

政府的一项责任是确保当地工业为人们提供安全有效的药物来治疗疾病和保持健康。然而,这些药物对公众的费用必须是这样的,即不能因为经济障碍而拒绝获得这些药物。仅可获得性并不能确保最大限度地提高健康成果。还必须建立让所有利益攸关方参与确保药品质量使用的结构和程序。所有这些组成部分都需要纳入一项国家协调政策,作为适当药物使用、政策制定和评价的参考点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Australian National Medicinal Drug Policy

Abstract A responsibility of Government is to ensure that safe and efficacious medicines are available for people, from local industry, to treat illness and to maintain health. However, the cost of these medications to the public must be such that access is not denied because of financial barriers. Accessibility alone does not ensure that health outcomes are maximized. It is also necessary to have in place structures and processes which involve all stakeholders in ensuring the quality use of medicines. All of these components need to be incorporated in a national, co-ordinated policy which acts as a reference point for appropriate drug use, policy development and evaluation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Health technology assessment. Notices Letters to the Editor Notices Author index
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1